Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...

Women whose breast cancers need estrogen to grow are often treated for five or more years with medications to lower estrogen production or block its effects. Broadly known as endocrine therapy, the ...

Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

Dr. Boris Naraev, a medical oncologist specializing in patient care for those suffering from gastrointestinal, neuroendocrine and endocrine tumors, has joined Tampa General Hospital’s (TGH) Cancer ...

Belle Gibson claimed to have cured her cancer through healthy eating and alternative therapies, but it was all a lie - and ...

Researchers analyzed data on 215 women diagnosed with stages 0-III breast cancer between January 2000 and October 2024 who ...

Researchers surveyed survivors of early-stage hormone receptor-positive breast cancer who did not receive chemotherapy to assess the symptom burden in this patient population.

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Breast cancer (BC) is the most common malignancy among females worldwide. Breast cancer is a highly heterogeneous malignant tumor which is constitutive of ...

Donald Patrick McDonnell, Ph.D., has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer, the ...